
On July 23, 2026, Cipla Limited reported its unaudited consolidated financial results for the quarter ending June 30, 2026, as per the exchange filings.
The company reported total incomeof ₹7,330.18 crore and net profit of ₹785.55 crore for the quarter ending June 30, 2026.
In the June 2026 quarter, Cipla's total income reached ₹7,330.18 crore, marking a 1.6% YoY increase from ₹7,216.03 crore.
This also reflects a 9.6% quarter-on-quarter (QoQ) growth from ₹6,689.36 crore in the March 2026 quarter.
However, the net profit (PAT) for the June 2026 quarter decreased by 39.2% YoY to ₹785.55 crore, down from ₹1,291.61 crore in the same period last year.
Despite this drop, the net profit showed a 44.8% QoQ increase from ₹542.51 crore in the March 2026 quarter.
For the financial year 2026, Cipla's total income was reported at ₹29,044.60 crore. The net profit for the year stood at ₹3,861.74 crore. These figures provide a comprehensive view of the company's financial performance over the year, highlighting both income and profitability metrics.
Read More: IndusInd Bank Share Price Falls Over 5% on July 23, 2026, After Q1 FY27 Results; Net Profit Jumps 72% YoY!
Cipla is a prominent Indian multinational pharmaceutical and biotechnology company headquartered in Mumbai. Founded in 1935, it specializes in producing high-quality, affordable generic drugs, APIs, and advanced drug delivery systems for conditions like HIV/AIDS, cancer, and respiratory diseases.
As of July 23, 2026, at 12:35 PM, Cipla share price on NSE was trading at ₹1,383.40, down by 2.24% from the previous closing price.
Cipla Limited's financial results for the June 2026 quarter reveal a 1.6% YoY increase in total income to ₹7,330.18 crore and a 39.2% YoY decrease in net profit to ₹785.55 crore. The company's annual total income was ₹29,044.60 crore, with a net profit of ₹3,861.74 crore.
Track the stock market in Hindi. Visit Angel One News for the latest market trends, insights, and share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jul 23, 2026, 12:52 PM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
